Amphotericin B cholesteryl sulfate contraindications: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{mphotericin B cholesteryl sulfate}} {{CMG}}; {{AE}} {{AZ}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMPHOTEC (AMPHOTERICIN B) I...") |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMPHOTEC (AMPHOTERICIN B) INJECTION, LIPID COMPLEX [INTERMUNE, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9b8ea543-1de8-472f-9666-34f99ca2f183 | publisher = | date = | accessdate = }}</ref> | ==Contraindications== | ||
AMPHOTEC should not be administered to patients who have documented hypersensitivity to any of its components, unless, in the opinion of the physician, the advantages of using AMPHOTEC outweigh the risks of hypersensitivity.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMPHOTEC (AMPHOTERICIN B) INJECTION, LIPID COMPLEX [INTERMUNE, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9b8ea543-1de8-472f-9666-34f99ca2f183 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Revision as of 06:40, 10 January 2014
Template:Mphotericin B cholesteryl sulfate Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Contraindications
AMPHOTEC should not be administered to patients who have documented hypersensitivity to any of its components, unless, in the opinion of the physician, the advantages of using AMPHOTEC outweigh the risks of hypersensitivity.[1]
References
Adapted from the FDA Package Insert.